Invivyd, Inc. (IVVD)
Nasdaq: IVVD · Biological Products, (No Diagnostic Substances) · New Haven, CT · filing with the SEC since 2020
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2021 | FY 2021 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 5, 2026 | Mar 20, 2025 | Mar 28, 2024 | Mar 23, 2023 | Mar 31, 2022 | · | · | · | · |
| Revenue | 53,426 | 25,384 | 0 | · | · | · | · | · | · |
| Research and development | 38,308 | 137,254 | 158,658 | 179,214 | 182,891 | · | · | · | · |
| Selling, general and administrative | 66,931 | 63,388 | 49,125 | 47,044 | 36,517 | · | · | · | · |
| Total operating expenses | 108,986 | 202,260 | 212,758 | 248,031 | 226,908 | · | · | · | · |
| Total costs and expenses | 108,986 | 202,260 | 212,758 | · | · | · | · | · | · |
| Operating income | -55,560 | -176,876 | -212,758 | -248,031 | -226,908 | · | · | · | · |
| Interest income (expense), net | 3,107 | 7,216 | 14,162 | · | · | · | · | · | · |
| Total non-operating income (expense) | 3,071 | 6,951 | 14,115 | 6,714 | 118 | · | · | · | · |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | · | · | · | · |
| Net income including non-controlling interests | -52,489 | -169,925 | -198,643 | -241,317 | -226,790 | · | · | · | · |
| Net income | -52,489 | -169,925 | -198,643 | -241,317 | -226,790 | -143,748 | -83,373 | -38,700 | · |
| Earnings per share, basic | -0.30 | -1.43 | -1.81 | -2.23 | -5.32 | · | · | · | · |
| Earnings per share, diluted | -0.30 | -1.43 | -1.81 | -2.23 | -5.32 | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -5.32 | · | · | · | · |
| Weighted average shares, basic | 172,212,902 | 118,555,073 | 109,526,053 | 108,268,289 | 42,621,265 | · | · | · | · |
| Weighted average shares, diluted | 172,212,902 | 118,555,073 | 109,526,053 | 108,268,289 | 42,621,265 | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 42,621,265 | 20,346,771 | 125,574 | · | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesTotal costs and expenses every operating cost, the cost of revenue included
us-gaap:CostsAndExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted